Skin and So) Tissue Infec1ons: MRSA and Beyond
|
|
- Barnard Greer
- 5 years ago
- Views:
Transcription
1 Overview Skin and So) Tissue Infec1ons: MRSA and Beyond Catherine Liu, M.D. Assistant Clinical Professor Division of Infec1ous Diseases University of California, San Francisco 2011 IDSA MRSA Treatment Guidelines Management of skin and so) 1ssue infec1ons (SSTI) Abscesses Celluli1s (purulent vs. non- purulent) Complicated SSTI Animal Bites Necro1zing fascii1s Other SSTI Case 1 What is the appropriate management of this pa1ent? 20 y/o M presents with 3 days of an enlarging, painful lesion on his L arm that he avributes to a spider bite T 36.9 BP 118/70 P 82 A. Incision and drainage alone B. Incision and drainage plus oral an1- MRSA an1microbial agent C. Oral an1- MRSA an1microbial agent 1
2 Abscesses Incision and drainage is the primary treatment (AII). For simple abscesses or boils, I&D alone likely adequate Do an1bio1cs provide addi1onal benefit? Clinical cure p=.25 p=.12 cephalexin TMP-SMX TMP-SMX p=.52 An1bio1c therapy is recommended for abscesses associated with: Severe, extensive disease, rapidly progressive with associated celluli1s or sep1c phlebi1s Signs & sx of systemic illness Associated comorbidi1es, immunosuppressed Extremes of age Difficult to drain area (e.g. face, hand, genitalia) Failure of prior I&D (AIII) 1 Rajendran AAC 2007; 2 Duong Ann Emerg Med 2009; 3 Schmitz G Ann Emerg Med 2010 Liu CID 2011; 52: Microbiology of Purulent SSTIs: ER Pa1ents Purulent Celluli1s viridans strep; 2% B- hemoly3c strep; 2% coag neg staph; 6% MSSA 16% other/ unknown, 15% MRSA 59% Celluli1s associated with purulent drainage or exudate without a drainable abscess Empiric Rx for CA- MRSA is recommended (AII). Empiric Rx for β- hemoly1c strep unlikely needed (AII). Dura1on of therapy: 5-10 days, individualize based on clinical response Moran NEJM 2006; Talan CID 2011 Liu CID 2011; 52:
3 Outpa1ent purulent celluli1s: Empiric Rx for CA- MRSA Case 2 TMP/ SMX 1-2 DS tab BID Doxycycline, Minocycline 100 mg BID Clindamycin TID Linezolid 600 mg BID MRSA MSSA β- hemoly3c strep Comments Low rates of resistance Low rates of resistance +/- ( resistance) + + C. diff risk Most expensive op1on 28 year old woman with erythema of her le) foot x 48 hours. No purulent drainage, exudate or abscess. T 37.0 BP 132/70 P 78 Eells SJ et al Epidemiology and Infec1on 2010 What is the appropriate management of this pa1ent? A. Clindamycin 300 mg PO 1d B. Cephalexin 500 mg QID, monitor clinically with addi1on of TMP/SMX if no response C. Cephalexin 500 mg QID and TMP/ SMX 2 DS tab PO bid Nonpurulent Celluli1s: β- hemoly1c strep vs. staph? Empiric Rx for β- hemoly1c strep recommended (AII) Prospec1ve study 1, 248 hospitalized pts 73% due to β- hemoly3c strep 27% with no iden1fied cause. Overall 96% response rate to β- lactam an1bio1c (cefazolin, oxacillin, cephalexin, dicloxacillin). Retrospec1ve study 2 treatment failures with TMP- SMX vs. β- lactam or clindamycin Consider coverage for MRSA if: Penetra1ng trauma, IVDU Evidence of MRSA infec1on elsewhere Failure to respond to β- lactam Systemic signs and symptoms 1 Jeng et al Medicine 2010; 2 EllioV et al Pediatrics 2009; Liu CID 2011; 52:
4 Cephalexin vs. Cephalexin + TMP- SMX in pa1ents with Uncomplicated Celluli1s Outpa1ent nonpurulent celluli1s: Empiric Rx for β- hemoly1c streptococci, +/- MRSA N=146 MRSA MSSA β- hemoly3c strep Cephalexin 500 mg QID Dicloxacillin 500 mg QID Clindamycin mg TID /- ( resistance) + + Linezolid 600 mg BID Pallin CID hospitalized pa1ents with celluli1s, abscess, complicated SSTI 97% of cases had S. aureus or Streptococcus spp. 74% S. aureus or Streptococcus ONLY Microbiology of SSTI: Hospitalized Pa1ents Enterococci 3% Implementa1on of a clinical prac1ce guideline for inpa1ent celluli1s and abscess July : Empiric Rx: IV vancomycin, then tailor to culture, step- down to PO therapy for 5-7 days Specifically discouraged: Gram nega1ve and an1- anaerobic agents ESR CRP Plain films, CT, MRI Developed electronic admission order set Educa1onal campaign for faculty and housestaff peer champions from 5 departments (ER, adult urgent care, internal medicine, general surgery, orthopedic surgery) Audit/ feedback Jenkins CID 2010; 51: Jenkins Arch Intern Med 2011; 171:
5 An1bio1c U1liza1on Post- Interven1on * Other Outcomes Median dura1on of Rx (13 vs. 10d, p<.001) * No differences in clinical outcomes Clinical failure (7.7% vs. 7.4%, p=ns) Recurrent infec1on * * *p<.05 Rehospitaliza1on due to SSTI Length of hospital stay Jenkins Arch Intern Med 2011; 171: Jenkins Arch Intern Med 2011; 171: Complicated SSTI Surgical debridement & empiric Rx for MRSA pending cx An1bio1c Adult Evidence Grade Vancomycin mg/kg IV Q8-12 AI Linezolid 600 mg PO/ IV BID AI Daptomycin 4 mg/kg IV QD AI Telavancin 10 mg/kg IV QD AI Clindamycin 600 mg PO/IV Q8 AIII Ce)aroline 600 mg IV Q12 FDA approved a)er guidelines Tigecycline 100 mg IV x 1, then 50 IV Q12 Consider alternate agent as associated with mortality Liu CID 2011; 52: What about Decoloniza1on for Preven1on of Recurrent SSTI? Mupirocin containing regimens (+/- chlorhexidine, bleach) reduce S. aureus coloniza1on S1ll no clear data that shows decoloniza1on prevents recurrent SSTI Open- label RCT of 300 pts with SSTI and S. aureus coloniza1on No difference in recurrent SSTI with hygiene educa1on alone vs mupirocin + hygiene educ. vs mupirocin/ CHG + hygiene educ. vs mupirocin/ bleach + hygiene educ. Fritz ICHE 2011; 32:
6 Household vs. Individual Decoloniza1on? Open- label RCT children with community- onset SSTI and S. aureus coloniza1on (nares, axilla, inguinal) 2 Index case vs. household decoloniza1on (mupirocin + CHG baths x 5d) All received hygiene educa1on: Avoid sharing personal hygiene items Use liquid pump or pour soaps and lo1ons (vs. bar soaps and lo1on jars) Launder towels and washcloths a)er each use Launder bed linens once weekly No difference in rate of eradica1on of S. aureus 1 month: 50% vs. 51% (p = 12 months: 54% vs. 66% (p=.28) Liu CID 2011; 52: Fritz CID 2012; 54: Recurrent SSTI among Cases and Household Contacts p=.02 p=.008 p=.02 Summary: empiric management of SSTIs Uncomplicated I&D Purulent (MRSA) Consider addi1on of an1- MRSA an1bio1c in select situa1ons 1 Non- purulent (β- hemoly1c strep) Cephalexin 500 QID Dicloxacillin 500 QID Consider MRSA ac1ve agent in select situa1ons 2 p=.12 Fritz CID 2012; 54: Complicated I&D plus vancomycin (or alterna1ve),no gram neg in most cases 3 Vancomycin (or alterna1ve), no gram neg in most cases 3 1. Systemic illness, purulent celluli1s/wound infec1on, comorbidi1es, extremes of age, abscess difficult to drain or face/hand, sep1c phlebi1s, lack of response of to I&D alone. PO an1bio1c : TMP- SMX 1-2 DS BID, Clindamycin 300 mg TID, Doxycycline 100 PO BID 2. Penetra1ng trauma (e.g. IVDU), evidence of MRSA elsewhere, failure to respond to β- lactams, systemic illness 3. Except: cri1cally ill pts with serious SSTI (nec fasc), perirectal/ periorbital infec1ons, decubitus ulcer infec1ons, severe diabe1c foot infec1ons, animal bites, water- exposure 6
7 Case 3 21 yo M is tossing a ball in Golden Gate Park with a friend. As he goes a)er the ball, he passes close to a dog that was res1ng in the shade with his owner. The dog jumps up and bites him on the leg inflic1ng several deep puncture wounds on the calf. In addi1on to wound care, what is the appropriate management of this pa1ent? A. An1bio1c prophylaxis with clindamycin B. An1bio1c prophylaxis with amoxicillin/ clavulanate C. Administer rabies immunoglobulin and rabies vaccine for post- exposure prophylaxis D. A and C E. B and C Microbiology of Animal Bites: What s in your mouth and on your skin Average 5 organisms (range 0-16) per wound Dogs Cats Pasturella sp 50% 75% Streptococcus sp. 46% 46% Staphylococcus aureus 20% 4% Anaerobes mixed w/ aerobes 48% 63% Anaerobes alone 1% 0% Talan NEJM 1999 An1bio1c Coverage for Pasteurella What you want to use but won t work cephalexin dicloxacillin clindamycin What works Amoxicillin/ penicillin doxycycline fluoroquinolones 7
8 Animal bites Rabies what type of bites are high risk? Empiric treatment regimens Amoxicillin/clavulanic acid +/- an1- MRSA Pen allergy: cipro + clindamycin or moxifloxacin Prophylaxis? Moderate- severe bites or on face/hands Immunocompromised (splenectomized) Cat bites (50% infec1on risk) Animal Type Dog, cats, ferrets Skunk, raccoons, foxes, bats Livestock, small rodents, rabbits, large rodents Evalua1on and disposure of animal Suspected/confirmed rabid Healthy Animal lost Regarded as rabid unless proven nega1ve by lab test Consider individually Post- exposure prophylaxis Prophylaxis 10 days observa1on/test Contact DPH Immediate prophylaxis Almost never require prophylaxis 39 yo M IVDU with 1 day h/o L leg pain and erythema, worsening pain and swelling x 24 hours T 39.2 P120 BP96/60 R22 98%RA Case 3 What would your empiric therapy be in this case? A. Admit, IV vancomycin and piperacillin- tazobactam B. Call surgery, IV vancomycin and clindamycin C. Call surgery, IV vancomycin, piperacillin- tazobactam, clindamycin 18>40<425, le) shi) 8
9 Necro1zing skin and so) infec1ons Monomicrobial (Group A strep > S. aureus, Clostridia, gram neg rare) Polymicrobial (gram +, gram -, anaerobes) associated w/ abdominal surgery, decub ulcers, IVDU, spread from GU tract Risk Factors for Necro3zing SSTI IVDU Diabetes Obesity Chronic immunosuppression O)en no precipita1ng factor Anaya DA. Clin Infect Dis Clinical Presenta1on Nonspecific complaints: pain, GI (N/V/D), influenza- like symptoms Physical exam difficult to dis1nguish from celluli1s, some1mes only mild local erythema pain out of propor3on Missed Dx of Necro1zing Fascii1s Ini3al Diagnoses by PCP/ ER No. Musculoskeletal Pain 6 (40%) Influenza 3 (20%) Gastroenteri1s 2 (13%) Hemorrhoids 1 (6%) Gout 1 (6%) 1 burn 1 (6%) Varicella 1 (6%) Bisno CID 2000 Wong CH Crit Care Med 2004 % of pa3ents Necro1zing so) 1ssue infec1ons: physical findings on admission Tenderness Erythema Warmth Bullae Indura1on Fluctuance n=89; 14% dx with nec fasc on admit Late findings Crepitus Necrosis Sensory/ motor deficits Hypotension Fever Tachycardia Wong CH. Jour of Bone and Joint Surg
10 Necro1zing so) 1ssue infec1ons: radiographic techniques Why is Early Diagnosis So Important? Plain films Low sensi1vity Helpful if gas present CT and ultrasound May iden1fy other Dx (abscess) MRI Enhanced sensi1vity, low specificity Dufel S, Martino M. J Fam Pract. 2006;55(5):396. Wong CH. J of Bone and Joint Surg Summary: Management of necro1zing skin and so) 1ssue infec1ons Early surgical consult/ interven3on Empiric an1microbial therapy Piperacillin/tazobactam or carbapenem (group A strep, other gram pos, gram negs and anaerobes) plus Clindamycin (group A strep toxin inhibifon) plus Vancomycin (MRSA) 53 yo M ER physician presents with 9 day history of progressive celluli1s of L forearm. Ini1ally noted a pustule self I&D, started keflex + clindamycin x 4 days. Progressive erythema and drainage. Started IV vanco + ce)riaxone with no improvement a)er 3 days. Case 4 10
11 Further history History of chronic benign neutropenia 3 weeks ago, trip to Arizona where cleared brush in order to replace a water drip line and scraped his arm 2 weeks ago, worked in home (Merced) vegetable garden clearing eggplant and pepper brushes 7 days ago, cleaned his fish tank No animal or 1ck bites Only recent travel to Arizona All of the following are possible causes of his infec1on EXCEPT: A. Mycobacterium marinum B. Coccidioides immifs C. Nocardia brasiliensis D. Brucella melitensis E. Sporothrix schenkii Gram stain from wound culture Nocardia brasiliensis Nocardia Soil inhabitant Worldwide distribu1on Incuba1on period: <1-6 weeks O)en with mild systemic symptoms Nocardia brasiliensis > asteroides for cutaneous disease Diagnosis: biopsy and culture Par1ally acid- fast, gram variable branching rods. Treatment: TMP- SMX x 4-6 months 11
12 26 yo M with 6 week history of R hand papule ulcer Mul1ple visits to ED and urgent care, Receives several courses of abx, no improvement Leishmania panamensis Approach to Nodular lymphangi1s Take a good history Obtain biopsy Pathology: stain for fungi and mycobacteria Cultures: bacterial, fungal, and mycobacterial Consider empiric therapy based on severity of disease and history prior to biopsy results Common causes: Sporothrix schenckii, Nocardia, Mycobacterium marinum, Francisella tularensis, Leishmania spp. 12
13 Which of the following reflect true infec1ous celluli1s? Which of the following reflect true infec1ous celluli1s? True celluli1s Acute on chronic stasis derma11s Acute stasis derma11s Contact derma11s David Derm Online J 2011 Masqueraders of Infec1ous Celluli1s Summary Stasis derma11s Superficial thrombophlebi1s and deep venous thrombosis Contact derma11s Insect s1ngs/1ck bites Drug reac1ons Gouty arthri1s Foreign body reac1on (e.g. surgical mesh, orthopedic implants) Lymphedema Malignancy (e.g. T- cell lymphoma) Falagas ME Ann Intern Med
14 Thank you! 14
A. Incision and drainage alone B. Incision and drainage plus oral anti-mrsa antimicrobial agent C. Oral anti-mrsa antimicrobial agent
Update: 2011 IDSA MRSA Treatment Guidelines Skin and soft tissue infections (SSTIs) Necrotizing fasciitis Animal bites Other skin and soft tissue infections Catherine Liu, M.D. Assistant Clinical Professor
More information4/28/11. Update: 2011 IDSA MRSA Treatment Guidelines. Necrotizing fasciitis Animal bites Other skin and soft tissue infections
Catherine Liu, M.D. Assistant Clinical Professor Division of Infectious Diseases University of California, San Francisco Update: 2011 IDSA MRSA Treatment Guidelines Skin and soft tissue infections (SSTIs)
More informationOverview Management of Skin and Soft Tissue Infections in the MRSA Era
Overview Management of Skin and Soft Tissue Infections in the MRSA Era April 2011 2011 IDSA MRSA Treatment Guidelines Skin and soft tissue infections (SSTIs) Management of Recurrent SSTIs Necrotizing soft
More informationAnnual U.S. ED Visits for Skin and Soft Tissue Infections,
Abscess, cellulitis Recurrent skin and soft tissue infections Necrotizing fasciitis Animal bites Unusual skin and soft tissue infections Catherine Liu, M.D. Assistant Clinical Professor Division of Infectious
More information5/26/10. Abscess, cellulitis Recurrent skin and soft tissue infections Necrotizing fasciitis Animal bites Unusual skin and soft tissue infections
Catherine Liu, M.D. Assistant Clinical Professor Division of Infectious Diseases University of California, San Francisco Abscess, cellulitis Recurrent skin and soft tissue infections Necrotizing fasciitis
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationOptimizing Antibiotic Treatment of Skin and Soft Tissue Infections
Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections 15th Annual Rocky Mountain Hospital Medicine Symposium November 6, 2017 Tim Jenkins, MD Director, Antibiotic Stewardship Program Denver
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More informationNecrotizing Soft Tissue Infections: Emerging Bacterial Resistance
Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance Eileen M. Bulger, MD Professor of Surgery Harborview Medical Center University of Washington Objectives Review definition & diagnostic
More information5/17/2012 DISCLOSURES OBJECTIVES CONTEMPORARY PEDIATRICS
CONTEMPORARY PEDIATRICS Surgical Management of MRSA Soft Tissue Infections John M. Draus, Jr., M.D. Assistant Professor of Surgery and Pediatrics Kentucky Children s Hospital University of Kentucky DISCLOSURES
More informationCellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018
Cellulitis Assoc Prof Mark Thomas Conference for General Practice Auckland Saturday 28 July 2018 Summary Cellulitis Usual treatment flucloxacillin for 5 days Frequent recurrences consider penicillin 250mg
More informationSkin and Soft Tissue Infections Emerging Therapies and 5 things to know
2011 MFMER slide-1 Skin and Soft Tissue Infections Emerging Therapies and 5 things to know Aaron Tande, MD Assistant Professor of Medicine October 27, 2017 Division of INFECTIOUS DISEASES 2011 MFMER slide-2
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationSkin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections. Skin & Soft Tissue Infections (SSTI)
Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections 2007 Abscess Cellulitis Bradley W Frazee, MD, FACEP Dept of Emergency Medicine Alameda County Medical Center - Highland Hospital Associate
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationDiscussion Points. Decisions in Selecting Antibiotics
Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical
More informationInfectious Disease Update 2017
Infectious Disease Update 2017 Greg Moran, MD, FACEP, FIDSA Professor of Clinical Emergency Medicine Geffen School of Medicine at UCLA Dept. of Emergency Medicine and Division of Infectious Diseases Olive
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationAntibiotic Updates: Part I
Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationDisclosures. Consider This Case. Objectives. Consequences of Bites. Animal Bites: What to Do and What to Avoid. Animal Bites: Epidemiology
Animal Bites: What to Do and What to Avoid Meg Fisher, MD Medical Director Disclosures I have no disclosures I do not plan to discuss off label uses of drugs Objectives Manage a child who is bitten Discuss
More informationCopyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at
Malignant Otitis Externa Inflammation and damage at the base of the skull due to an untreated outer ear P. aeruginosa most common organism Yellow-green drainage from the ear Odor Fever Deep inner ear pain
More informationMRSA Background. New Challenges From an Old Foe. MRSA Demographics. Comparison of Types of MRSA CA-MRSA HA-MRSA
Winter Clinical 2017 : MRSA Update Whitney A. High, MD, JD, Meng whitney.high@ucdenver.edu Associate Professor, Dermatology & Pathology Director of Dermatopathology University of Colorado School of Medicine
More informationMrsa abscess and cellulitis
Search Mrsa abscess and cellulitis An abscess is a collection of pus that has built up within the tissue of the body. Signs and symptoms of abscesses include redness, pain, warmth, and swelling. The. Staph
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 3 PURPOSE To assure that DOP inmates with Soft Tissue Infections are receiving high quality Primary Care for their infections and that the risk of infecting other inmates or staff is minimized.
More informationFelipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare
Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare 100% of all wounds will yield growth If you get a negative culture you something is wrong! Pseudomonas while ubiquitous does
More informationCLINICAL USE OF BETA-LACTAMS
CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial
More informationReplaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION
Effective Date: 04/13/17 Replaces:04/14/16 Page 1 of 7 POLICY To standardize the clinical management and housing of offenders with skin and soft tissue infections, thereby reducing the transmission and
More informationS aureus infections: outpatient treatment. Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium
S aureus infections: outpatient treatment Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium Intern Med J. 2005 Feb;36(2):142-3 Intern Med J. 2005 Feb;36(2):142-3 Treatment of
More informationDiagnosis and Management of Skin and Soft-tissue Infections
Diagnosis and Management of Skin and Soft-tissue Infections Skin and soft tissue infections (SSTIs), are referred as skin and skin structure infections. These infections also represent a group of infections
More informationThe Bug Stops Here: Treating Resistant Staph Infections Holly Roberts, DVM, MS, DACVD Blue Pearl Veterinary Specialists San Antonio, TX
The Bug Stops Here: Treating Resistant Staph Infections Holly Roberts, DVM, MS, DACVD Blue Pearl Veterinary Specialists San Antonio, TX 1. Staphylococcus bacteria a. Gram positive b. Opportunistic pathogens
More informationPVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust
PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust Neonatal Case History Neonate born at 26 +2 gestation Spontaneous onset of
More informationAntibiotic Stewardship
Antibiotic Stewardship Nick Zaksek Pharm D., BCPS AQ-ID Infectious Disease POMA 2019 1 Disclosures None 2 Objectives Practice good Antibiotic stewardship and foster the notion of antibiotic stewardship
More informationStaph Cases. Case #1
Staph Cases Lisa Winston University of California, San Francisco San Francisco General Hospital Case #1 A 60 y.o. man with well controlled HIV and DM presents to clinic with ten days of redness and swelling
More informationCan you treat mrsa with amoxicillin
Can you treat mrsa with amoxicillin 15-8-2017 Community-associated MRSA You can pick up MRSA outside the hospital, especially if you :. (a related drug developed to treat these germs). Amoxicillin and
More informationDiabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals
Diabetic Foot Infection Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals History of previous amputation [odds ratio (OR)=19.9, P=.01], Peripheral vascular disease (OR=5.5, P=.007)
More informationCentral Nervous System Infections
Central Nervous System Infections Meningitis Treatment Bacterial meningitis is a MEDICAL EMERGENCY. ANTIBIOTICS SHOULD BE STARTED AS SOON AS THE POSSIBILITY OF BACTERIAL MENINGITIS BECOMES EVIDENT, IDEALLY
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationBacterial skin infection
D i v i s i o n o f P e d i a t r i c E m e r g e n c y M e d i c i n e P a g e 1 Bacterial skin infection Cellulitis w/o abscess Abscess Deep tissue involvement Multiple abscesses Perirectal Anterior
More informationRisk factors? Insect bites? Hygiene? Household crowding Health literacy
Recurrent boils Commonest sites face, neck, armpits, shoulders, and buttocks (bottom) infection of the hair root or sweat pore Occur in otherwise healthy people (higher rates in diabetics, eczema, iron
More informationAntibiotic Use in the Emergency Department
Antibiotic Use in the Emergency Department Fredrick M. Abrahamian, D.O., FACEP Associate Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationNew Antibiotics & New Insights into Old Antibiotics
New Antibiotics & New Insights into Old Antibiotics Louisiana Chapter of the American Academy of Pediatrics August 18, 2018 Baton Rouge, Louisiana John Bradley MD Rady Children s Hospital San Diego University
More informationTropical infections caused by Staphylococcus aureus
Tropical infections caused by Staphylococcus aureus Michael Ellis, MD Infectious Diseases Division Uniformed Services University of the Health Sciences February 2015 Introduction Tropical Pyomyositis Cutaneous
More informationIntra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018
Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection
More informationCommunity Methicillin- Resistant Staphylococcus aureus. Sixth Plague of Egypt. Epidemiology
Community Methicillin- Resistant Staphylococcus aureus Henry F. Chambers, M.D. University of California San Francisco San Francisco General Hospital Sixth Plague of Egypt (~ 1200 BCE) So they took soot
More informationObjectives. Review basic categories of intra-abdominal infection and their respective treatments. Community acquired intra-abdominal infection
Objectives Review basic categories of intra-abdominal infection and their respective treatments Community acquired intra-abdominal infection Mild/Moderate Severe Acute biliary tract infections Nosocomial
More informationDirty Wounds. Christopher M. Ziebell, MD, FACEP
Dirty Wounds Christopher M. Ziebell, MD, FACEP Types Fresh Water Salt Water Bites Cats Humans Dogs and other mammals Freshwater Trauma Recognize this finger? Lindsey Lohan Microbiology Usual suspects:
More informationResponders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)
Infectious Diseases Society of America Emerging Infections Network 6/2/10 Report for Query: Perioperative Staphylococcus aureus Screening and Decolonization Overall response rate: 674/1339 (50.3%) physicians
More informationMeropenem for all? Midge Asogan ICU Fellow (also ID AT)
Meropenem for all? Midge Asogan ICU Fellow (also ID AT) Infections Common reason for presentation to ICU Community acquired - vs nosocomial - new infection acquired within hospital environment Treatment
More information2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY
Canadian Nosocomial Infection Surveillance Program 2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY FINAL Working Group: E. Henderson, M. John, I. Davis, S. Dunford,
More informationLe infezioni di cute e tessuti molli
Le infezioni di cute e tessuti molli SCELTE e STRATEGIE TERAPEUTICHE Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Treatment of complicated skin and skin structure infections
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationWhat s New in MRSA? An Update on Legislative Mandates and MRSA in the Obstetrics/ Gynecology Patient
What s New in MRSA? An Update on Legislative Mandates and MRSA in the Obstetrics/ Gynecology Patient Catherine Liu, M.D. Assistant Clinical Professor University of California, San Francisco Overview New
More informationSixth Plague of Egypt. Community MRSA. Epidemiology. Basic Features of Community MRSA. Populations with CA-MRSA
Community MRSA Henry F. Chambers, M.D. University of California San Francisco San Francisco General Hospital Sixth Plague of Egypt (~ 1200 BCE) So they took soot from a kiln, and stood before Pharaoh;
More informationCELLULITIS / SKIN INFECTIONS
Skin Infections Assessment Investigations Cellulitis Management Abscess Management Infection Control Antibiotic Choice Education Recurrent Infections Referral to Community Nursing References Skin Infections
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More informationTreatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals
Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with
More informationCellulitis and Abscess: ED Phase v 1.1
Cellulitis and Abscess: ED Phase v 1.1 Executive Summary Test Your Knowledge PHASE I (E.D.) Explanation of Evidence Ratings Summary of Version Changes! Labs if systemic illness or necrotizing fasciitis
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationHead to Toe: Common infections in Hospital settings. Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases
Head to Toe: Common infections in Hospital settings Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases Objectives To identify at least one common infection in
More informationInfections caused by Methicillin-Resistant Staphylococcus
MRSA infections are no longer limited to hospitals. An infectious disease specialist offers insight on what this means for dermatologists. By Robert S. Jones, DO, Reading, PA Infections caused by Methicillin-Resistant
More informationSKIN AND SOFT TISSUE INFECTIONS OCTOBER 3-4, 2015
SKIN AND SOFT TISSUE INFECTIONS OCTOBER 3-4, 2015 Disclosures I have no financial conflicts of interest to disclose or report. Steven Tran, PharmD NEFSHP Fall Meeting 2015 Objectives for Pharmacists Review
More informationSource: Portland State University Population Research Center (
Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:
More informationSkin & Soft Tissue Infections (SSTIs)
Skin & Soft Tissue Infections (SSTIs) Marnie Peterson, Pharm.D., Ph.D. College of Pharmacy peter377@umn.edu (612) 626-4388 SSTIs Objectives To classify types of skin infections To present a case of cellulitis
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationFM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...
Jillian O Keefe Doctor of Pharmacy Candidate 2016 September 15, 2015 FM - Male, 38YO HPI: Previously healthy male presents to ED febrile (102F) and in moderate distress ~2 weeks after getting a tattoo
More information3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose
Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc Kathryn G. Smith: Nothing to disclose Describe the new updates and rationale for them Relay safety concerns with use of
More informationObjectives. Impetigo 8/6/2013
Bacterial Infections E.J. Mayeaux, Jr., M.D. Professor of Family Medicine Professor of Obstetrics & Gynecology Louisiana State University Health Sciences Center Shreveport, LA No disclosures to report.
More informationRichard A. Jacobs, M.D., PhD.
Richard A. Jacobs, M.D., PhD. Location of infx may help define bacteriology Primary infx (breach of intact skin) usually monomicrobial; Secondary infx (pre-existing abnormality) often polymicrobial Impaired
More informationAntimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood
Antimicrobial Prophylaxis in the Surgical Patient M. J. Osgood Outline Definitions surgical site infection (SSI) Risk factors Wound classification Microbiology of SSIs Strategies for prevention of SSIs
More information3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on
The Good Antibiotics: the Good, the Bad and the Ugly John P. Cello, MD Professor of Medicine and Surgery, University of California, San Francisco Most organisms can be readily identified by culture, special
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationProvincial Drugs & Therapeutics Committee Memorandum Version 2
Provincial Drugs & Therapeutics Committee Memorandum Version 2 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada
More informationHealth PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults
Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults COMMUNITY-ACQUIRED PNEUMONIA HEALTHCARE-ASSOCIATED PNEUMONIA INTRA-ABDOMINAL INFECTION
More informationCanadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING HIP AND KNEE ARTHROPLASTY
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING HIP AND KNEE ARTHROPLASTY FINAL Working Group: Dominik Mertz (Chair) Elizabeth Henderson, Johan
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationInfectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles
Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationAdvanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
More informationCA-MRSA lesions: What works, what doesn t
For mass reproduction, content licensing and permissions contact Dowden Health Media. FAMILY David McBride, MD University Student Health Services and the Department of Family Medicine, Boston University
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Community Acquired 1) Is it pneumonia? ie new symptoms and signs of a lower respiratory
More informationNew Antibiotics for MRSA
New Antibiotics for MRSA Faculty Warren S. Joseph, DPM, FIDSA Consultant, Lower Extremity Infectious Diseases Roxborough Memorial Hospital Philadelphia, Pennsylvania Faculty Disclosure Dr. Joseph: Speaker
More informationGuidelines for the Medical management of Diabetic Foot Infection
Guidelines for the Medical management of Diabetic Foot Infection Introduction and summary points - Foot infections in diabetic patients usually begin with skin ulceration - However, skin wounds with no
More informationUpdate on the Diagnosis and Management of O33s Media. Leslie Herrmann MD, FAAP Pediatrician
Update on the Diagnosis and Management of O33s Media Leslie Herrmann MD, FAAP Pediatrician Disclosures I have no financial disclosures. Objec3ves Understand the new diagnos3c criteria for OM Know when
More informationGetting Smart about Skin Infections and MRSA
Getting Smart about Skin Infections and MRSA Loren G. Miller, M.D., M.P.H. Associate Professor of Medicine David Geffen School of Medicine at UCLA Division of Infectious Diseases Director, Infection Control
More informationBest Antimicrobials for Staphylococcus aureus Bacteremia
Best Antimicrobials for Staphylococcus aureus Bacteremia I. Methicillin Susceptible Staph aureus (MSSA) A. In vitro - Anti-Staphylococcal β-lactams (Oxacillin, Nafcillin, Cefazolin) are more active B.
More informationSSTI s :A Guideline for Effective Treatment of Skin and Soft Tissue Infections
SSTI s :A Guideline for Effective Treatment of Skin and Soft Tissue Infections Dr. Javan S. Bass, FACFAS Metro Foot & Ankle Centers, PC Georgia Podiatric Association Board of Directors Disclosures Bako
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationAntibiotic Update 2015
Antibiotic Update 2015: Disclosures Antibiotic Update 2015 No Financial Conflicts of Interest Shireesha Dhanireddy, MD 23 April 2015 Current Concepts in Drug Therapy Antibiotic Update 2015: Outline Cystitis
More informationSummary of New Diabetic Foot Infection Guidelines (2015/2016 IWGDF)
Summary of New Diabetic Foot Infection Guidelines (2015/2016 IWGDF) Professor Kittipan Rerkasem Department of Surgery Faculty of Medicine Chiang Mai University A diabetic patient with feverchill, hypotension
More informationPocket Guide to Diagnosis & Treatment of Cardiovascular Implantable Electronic Device (CIED) Infections
Pocket Guide to Diagsis & Treatment of Cardiovascular Implantable Electronic Device (CIED) Infections Draft Version : November 208 DEFINITION Pocket infection, if all 4 criteria are fulfilled: Investigation/sign
More informationDisclosures. Nothing Medically I own FiPhysician LLC, a financial planning and investment company (FiPhysician.com)
"How to work around (with) administration to build an Antimicrobial Stewardship Program AND how to get dumb (oops reluctant) doctors to do the right thing" David Graham, MD Disclosures Nothing Medically
More informationMEMORANDUM. Re: New guidelines for the Management of Skin and Soft Tissue Infections where MRSA is prevalent
Athabasca Health Authority Keewatin Yatthé Health Region Mamawetan Churchill River Health Region Box 6000 La Ronge, SK S0J 1L0 Ph: 306-425-8588 Fax: 306-425-8530 MEMORANDUM To: Physicians and Primary Care
More informationAn Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery
An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery Nicholas Makhoul DMD. MD. FRCD(C). Dip ABOMS. FACS. Director, Division of Oral and Maxillofacial Surgery Assistant Professor McGill
More informationSymptoms of cellulitis (n=396) %
Cellulitis and lymphoedema Vaughan Keeley May 2012 What is cellulitis? - also called erysipelas, acute inflammatory episodes etc. - bacterial infection of skin + subcutaneous tissues - more common in people
More informationDuration of antibiotic therapy:
Duration of antibiotic therapy: How low can you go? Thomas Holland, MD Hilton Head, SC July 2017 Disclosures Consulting: The Medicines Company, Basilea Pharmaceutica Adjudication committee: Achaogen Grant
More informationMANAGEMENT OF TOTAL JOINT ARTHROPLASTY INFECTIONS
MANAGEMENT OF TOTAL JOINT ARTHROPLASTY INFECTIONS Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine TOTAL JOINT ARTHROPLASTIES In 2009: 1 million THA and TKA By 2030,
More informationFull Title of Guideline. Author: Contact Name and Job Title. Division & Speciality. Review date December 2020
Full Title of Guideline Author: Contact Name and Job Title Division & Speciality Guideline for the treatment of prosthetic joint infections in adults Mr Peter James - Consultant Orthopaedic Surgeon Dr
More information